Skip to main content
Fig. 4 | Lipids in Health and Disease

Fig. 4

From: Ganoderma terpenoid extract exhibited anti-plasmodial activity by a mechanism involving reduction in erythrocyte and hepatic lipids in Plasmodium berghei infected mice

Fig. 4

Serum aspartate aminotransferase, AST (a) and alanine aminotransferase, ALT (b) activities of Plasmodium berghei infected mice administered terpenoid extract of Ganoderma lucidum in combination with chloroquine over a period of 12 days. Values are means ± SEM of 5 or 8 determinations. Bars carrying different alphabets are significant (p < 0.05). Legend: Note: INF-CTR: Infected control, infected mice administered 1 mL dimethyl sulfoxide (DMSO); GT100: Infected mice administered Ganoderma terpenoid extract at 100 mg/kg body weight/mouse/day; GT250: infected mice administered Ganoderma terpenoid extract at 250 mg/kg body weight/mouse/day; CQ, Infected mice administered chloroquine at 30 mg/kg body weight/mouse/day; Note: INF-CTR: Infected control, infected mice administered 1 mL dimethyl sulfoxide (DMSO); GT100 + CQ: Infected mice administered a combination of Ganoderma terpenoid extract at 100 mg/kg plus 30 mg/kg chloroquine/mouse/day; GT250 + CQ: Infected mice administered a combination of Ganoderma terpenoid extract at 250 mg/kg plus 30 mg/kg chloroquine/mouse/day

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X